EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Polymerized Type I Collagen With Polyvinylpyrrolidone Reduces Fibrosis and Improves Nerve Organization and Myelination After Peripheral Nerve Injury

Daniel Salas‐Treviño, Adolfo Soto‐Domínguez, Roberto de Oca‐Luna Montes, Cynthia Minerva González‐Cantú, Everardo Valdés‐Flores, Mauricio Manuel García‐Pérez, Yanko Castro‐Govea

Neuropathology · 2025-08 · 45 (4)

DOI: 10.1111/neup.70012 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Peripheral nerve injuries (PNI) cause a partial or total deficit of sensory and motor function, producing neuropathic pain and loss of productivity in adults. Type I collagen polymerized with polyvinylpyrrolidone (CLG‐PVP) has been used previously in other fibrosing diseases due to its regulatory effects on interleukins, cytokines, and adhesion molecules. In the present study, we describe the role of CLG‐PVP in the repair of PNI. We used a murine model of PNI through axonotmesis of the sciatic nerve. CLG‐PVP treatments were administered in situ and intramuscularly and were compared to a sham procedure and placebo. Histological and histochemical‐specific stain evaluations were performed to describe the structural changes in nervous tissue. A significant reduction in tissue fibrosis was observed in the groups treated with CLG‐PVP, especially with the intramuscular treatment. Likewise, an increase in the organization of external lamina and nerve remyelination was observed in the treated groups. In addition, a slight improvement in gait was noted in the treated animal groups at the end of the study. After peripheral nerve injury, CLG‐PVP restores the nerve's function, structure, and tissue organization. These therapeutic effects were more evident through the intramuscular administration scheme with a weekly dosage. However, randomized controlled clinical trials should be performed to verify its beneficial effects and characterize adverse events.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →